Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/3/2017
SIETES contiene 91704 citas

 
 
 1 a 20 de 208 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Chobanian AV. Hypertension in 2017- What is the right target?. JAMA 2017;317:579-80. [Ref.ID 101415]
2. Cita con resumen
Anónimo. Hypertension artérielle essentielle chez un adulte: premiers traitements. Prescrire 2015;35:683-6. [Ref.ID 99722]
3.Tiene citas relacionadas Cita con resumen
Patel A, Cass A, Peiris D, Usherwood T, Brown A, Jan S, Neal B, Hillis GS, Tonkin A, Webster R, Billot L, Bompoint S, Burch C, Burke H, Hayman N, Molanus B, Reid CM, Shiel L, Togni S, Rodgers A, for the Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. European Journal of Preventive Cardiology 2015;22:920-30. [Ref.ID 99443]
4. Cita con resumen
Anónimo. Indapamide + amlodipine. Prescrire 2015;35:7. [Ref.ID 98895]
5.Tiene citas relacionadas Cita con resumen
Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Paraq V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. BMJ 2014;348:g3318. [Ref.ID 98026]
7. Cita con resumen
Trullàs JC, Morales-Rull JL, Formiga F. Tratamiento diurético en la insuficiencia cardíaca. Med Clin (Barc) 2014;142:163-70. [Ref.ID 97267]
8.Tiene citas relacionadas Cita con resumen
Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, Grobbee DE, Bots ML, Reddy KS, Cidambi R, Bompoint S, Billot L, Rodgers A, UMPIRE Collaborative Group. Effects of a fixed -dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA 2013;310:918-29. [Ref.ID 96053]
9.Tiene citas relacionadas
Gaziano JM. Progress with the polypill?. JAMA 2013;310:910-1. [Ref.ID 96052]
10.Tiene citas relacionadas
Dhalla IA, Mamdani MM, Juurlink DN. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:923-4. [Ref.ID 95693]
11.Tiene citas relacionadas
Einhom PT, Cushman WC, Whelton PK, for the ALLHAT Collaborative Research Group. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:922-3. [Ref.ID 95692]
12.Tiene citas relacionadas
Donzelli A. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:921-2. [Ref.ID 95691]
13.Tiene citas relacionadas
Badgett RG. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:921. [Ref.ID 95690]
14.Tiene citas relacionadas
DiNicolantonio JJ, O'Keefe JH, Lavie CJ. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:920-1. [Ref.ID 95689]
15.Tiene citas relacionadas
Roush GC, Holford TR, Guddati AK. Chlorthalidone versus hydrochlorothiazide. Ann Intern Med 2013;158:920. [Ref.ID 95688]
16.Tiene citas relacionadas
Weber MA, Bakris GL, Weir MR, Jamerson K. Obesity, blood pressure, and cardiovascular outcomes - Authors' reply. Lancet 2013;381:1982. [Ref.ID 95608]
17.Tiene citas relacionadas
Dong S, Mao B. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1982. [Ref.ID 95607]
18.Tiene citas relacionadas
Blankfield RP. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95606]
19.Tiene citas relacionadas
Barrios V, Escobar C. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95605]
20.Tiene citas relacionadas
Elijovich F, Laffer C. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95604]
Seleccionar todas
 
 1 a 20 de 208 siguiente >>